EquityZen Growth Technology Fund LLC - Series 1330
Raised
$180K
Investors
8
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1330 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on 2022-05-19, raising $180K from 8 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is part of the EquityZen platform, which operates 1889+ related EDGAR entities providing pre-IPO secondary market access through series-structured SPVs.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption combination typical of platforms offering accredited investor access to private company shares. The $10K minimum investment and sub-$200K raise size reflect EquityZen's retail-accessible structure for fractional pre-IPO exposure, consistent with the platform's model of creating discrete SPVs for individual secondary transactions.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
